share_log

健康元(600380.SH):注射用醋酸曲普瑞林微球新适应症获批

joincare pharmaceutical group industry (600380.SH): The new indication of injectable acetic acid quaprilin microspheres has been approved.

Gelonghui Finance ·  Oct 8 07:08

On October 8, Health元(600380.SH) announced that its holding subsidiary, Livzon Pharma Group Co., Ltd. (referred to as Livzon Pharmaceutical Group Inc.) and its holding subsidiary Shanghai Livzon Pharmaceutical Co., Ltd. have received the "Drug Registration Certificate" (Certificate Number: 2024S02341) issued by the National Medical Products Administration. The company's injection, acetic acid propylthiouraciland microsphere, with a new indication for "endometriosis", has been approved for registration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment